| 2009 |
Systemic manifestations and comorbidities of COPD. |
The European respiratory journal |
1194 |
19407051 |
| 2006 |
Mortality in COPD: Role of comorbidities. |
The European respiratory journal |
766 |
17138679 |
| 2020 |
Oxidative stress-based therapeutics in COPD. |
Redox biology |
366 |
32336666 |
| 2015 |
The relationship between COPD and lung cancer. |
Lung cancer (Amsterdam, Netherlands) |
329 |
26363803 |
| 2000 |
Oxidants/antioxidants and COPD. |
Chest |
283 |
10843965 |
| 2019 |
Benralizumab for the Prevention of COPD Exacerbations. |
The New England journal of medicine |
271 |
31112385 |
| 2004 |
Alveolar macrophages as orchestrators of COPD. |
COPD |
244 |
16997739 |
| 2009 |
Role of HDAC2 in the pathophysiology of COPD. |
Annual review of physiology |
243 |
18817512 |
| 2008 |
Obesity and the lung: 5. Obesity and COPD. |
Thorax |
231 |
19020276 |
| 2020 |
COVID-19 and COPD. |
The European respiratory journal |
216 |
32817205 |
| 2008 |
Pulmonary vascular involvement in COPD. |
Chest |
200 |
18842913 |
| 2002 |
Systemic effects in COPD. |
Chest |
195 |
12010840 |
| 2018 |
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. |
Autophagy |
192 |
30290714 |
| 2016 |
Senescence in COPD and Its Comorbidities. |
Annual review of physiology |
190 |
27959617 |
| 2011 |
Systemic manifestations of COPD. |
Chest |
161 |
21208876 |
| 2006 |
COPD exacerbations . 3: Pathophysiology. |
Thorax |
161 |
16565268 |
| 2013 |
Pathophysiology of muscle dysfunction in COPD. |
Journal of applied physiology (Bethesda, Md. : 1985) |
159 |
23519228 |
| 2015 |
COPD: balancing oxidants and antioxidants. |
International journal of chronic obstructive pulmonary disease |
147 |
25673984 |
| 2019 |
Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis. |
Journal of thoracic disease |
137 |
31737343 |
| 2016 |
COPD and the microbiome. |
Respirology (Carlton, Vic.) |
124 |
26852737 |
| 2014 |
Cytokine inhibition in the treatment of COPD. |
International journal of chronic obstructive pulmonary disease |
124 |
24812504 |
| 2014 |
Clinical issues of mucus accumulation in COPD. |
International journal of chronic obstructive pulmonary disease |
117 |
24493923 |
| 2022 |
Pathological Mechanism and Targeted Drugs of COPD. |
International journal of chronic obstructive pulmonary disease |
116 |
35855746 |
| 2019 |
Women and COPD: do we need more evidence? |
European respiratory review : an official journal of the European Respiratory Society |
112 |
30814138 |
| 2006 |
Reduced histone deacetylase in COPD: clinical implications. |
Chest |
111 |
16424426 |
| 2013 |
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. |
The European respiratory journal |
108 |
23794464 |
| 2019 |
Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update. |
Journal of thoracic disease |
100 |
31737350 |
| 2004 |
Genetics of COPD. |
Chest |
99 |
15136409 |
| 2012 |
Antioxidant pharmacological therapies for COPD. |
Current opinion in pharmacology |
95 |
22349417 |
| 2018 |
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses. |
Inflammation and regeneration |
94 |
30386443 |
| 2021 |
Natural history and mechanisms of COPD. |
Respirology (Carlton, Vic.) |
93 |
33506971 |
| 2008 |
COPD: a pediatric disease. |
COPD |
93 |
18259975 |
| 2006 |
Emerging role of MAP kinase pathways as therapeutic targets in COPD. |
International journal of chronic obstructive pulmonary disease |
89 |
18046891 |
| 2019 |
Chemokines in COPD: From Implication to Therapeutic Use. |
International journal of molecular sciences |
84 |
31174392 |
| 2008 |
Emerging pharmacotherapies for COPD. |
Chest |
84 |
19059958 |
| 2002 |
Cytokines and therapy in COPD: a promising combination? |
Chest |
74 |
12010854 |
| 2014 |
Management and prevention of exacerbations of COPD. |
BMJ (Clinical research ed.) |
71 |
25245156 |
| 2002 |
Airways inflammation and COPD: epithelial-neutrophil interactions. |
Chest |
70 |
12010843 |
| 2006 |
Antioxidant therapeutic targets in COPD. |
Current drug targets |
68 |
16787173 |
| 2018 |
Mitochondrial Quality Control in COPD and IPF. |
Cells |
67 |
30042371 |
| 2009 |
Associations between statins and COPD: a systematic review. |
BMC pulmonary medicine |
67 |
19594891 |
| 2002 |
Few smokers develop COPD. Why? |
Respiratory medicine |
67 |
12195843 |
| 2018 |
Chronic obstructive pulmonary disease (COPD) and lung cancer screening. |
Translational lung cancer research |
66 |
30050772 |
| 2016 |
ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects. |
American journal of human genetics |
64 |
27476655 |
| 2023 |
How inhaled corticosteroids target inflammation in COPD. |
European respiratory review : an official journal of the European Respiratory Society |
62 |
37852657 |
| 2005 |
Murine models of COPD. |
Pulmonary pharmacology & therapeutics |
60 |
16084119 |
| 2021 |
Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD. |
Antioxidants (Basel, Switzerland) |
59 |
34572965 |
| 2020 |
Extracellular matrix remodelling in COPD. |
European respiratory review : an official journal of the European Respiratory Society |
59 |
33208482 |
| 2017 |
Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD). |
Respiratory investigation |
59 |
28274525 |
| 2016 |
The inflammasome pathway in stable COPD and acute exacerbations. |
ERJ open research |
59 |
27730204 |
| 2014 |
Structural alterations of skeletal muscle in copd. |
Frontiers in physiology |
58 |
24678302 |
| 2011 |
COPD/emphysema: The vascular story. |
Pulmonary circulation |
57 |
22140621 |
| 2006 |
Antioxidant therapies in COPD. |
International journal of chronic obstructive pulmonary disease |
56 |
18046899 |
| 2021 |
Protein Biomarkers for COPD Outcomes. |
Chest |
53 |
33434499 |
| 2010 |
Lasers, stem cells, and COPD. |
Journal of translational medicine |
53 |
20158898 |
| 2018 |
Autophagy, selective autophagy, and necroptosis in COPD. |
International journal of chronic obstructive pulmonary disease |
52 |
30349225 |
| 2000 |
Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. |
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace |
52 |
11057087 |
| 2017 |
Decreased Serum Sirtuin-1 in COPD. |
Chest |
51 |
28506610 |
| 2009 |
Endocrinological derangements in COPD. |
The European respiratory journal |
51 |
19797671 |
| 2021 |
Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome. |
Archivos de bronconeumologia |
48 |
34172340 |
| 2020 |
Senotherapy: A New Horizon for COPD Therapy. |
Chest |
48 |
32057805 |
| 2008 |
Pulmonary hypertension associated with COPD. |
International journal of chronic obstructive pulmonary disease |
48 |
18488429 |
| 2022 |
Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD? |
Medicina (Kaunas, Lithuania) |
47 |
36013497 |
| 2015 |
Association between HMGB1 and COPD: A Systematic Review. |
Mediators of inflammation |
46 |
26798204 |
| 2021 |
Towards Personalized Management of Sarcopenia in COPD. |
International journal of chronic obstructive pulmonary disease |
45 |
33442246 |
| 2014 |
Targeting mucus hypersecretion: new therapeutic opportunities for COPD? |
Drugs |
45 |
24890395 |
| 2005 |
Selectin antagonists : therapeutic potential in asthma and COPD. |
Treatments in respiratory medicine |
45 |
15813660 |
| 2019 |
Extracellular vesicles in chronic obstructive pulmonary disease (COPD). |
Journal of thoracic disease |
44 |
31737342 |
| 2012 |
Epigenetics in asthma and COPD. |
Biochimie |
44 |
22874820 |
| 2006 |
Akt in the pathogenesis of COPD. |
International journal of chronic obstructive pulmonary disease |
44 |
18046900 |
| 2022 |
New drugs under development for COPD. |
Minerva medica |
43 |
35142480 |
| 2020 |
Lung epithelium damage in COPD - An unstoppable pathological event? |
Cellular signalling |
42 |
31953012 |
| 2020 |
Sputum microbiome profiling in COPD: beyond singular pathogen detection. |
Thorax |
42 |
31996401 |
| 2019 |
Targeting HDAC Complexes in Asthma and COPD. |
Epigenomes |
42 |
34968229 |
| 2014 |
Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery. |
Expert opinion on drug discovery |
42 |
24850530 |
| 2017 |
Macrophage phagocytosis cracking the defect code in COPD. |
Biomedical journal |
39 |
29433833 |
| 2015 |
Molecular pathogenesis of cigarette smoking-induced stable COPD. |
Annals of the New York Academy of Sciences |
38 |
25639503 |
| 2017 |
Emerging pharmaceutical therapies for COPD. |
International journal of chronic obstructive pulmonary disease |
37 |
28790817 |
| 2010 |
Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD. |
Thorax |
37 |
20965933 |
| 2020 |
Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review. |
COPD |
36 |
32558592 |
| 2019 |
Targeting IL-5 in COPD. |
International journal of chronic obstructive pulmonary disease |
36 |
31190789 |
| 2008 |
Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management. |
Proceedings of the American Thoracic Society |
36 |
19017738 |
| 2011 |
Pulmonary hypertension in COPD: pathophysiology and therapeutic targets. |
Current drug targets |
35 |
21194405 |
| 2022 |
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators. |
Inflammopharmacology |
34 |
35441963 |
| 2011 |
Mast cells and COPD. |
Pulmonary pharmacology & therapeutics |
34 |
21463700 |
| 2011 |
Genetics of COPD. |
Allergology international : official journal of the Japanese Society of Allergology |
33 |
21778810 |
| 2022 |
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview. |
Critical reviews in clinical laboratory sciences |
32 |
36420874 |
| 2015 |
MicroRNA-33a disturbs influenza A virus replication by targeting ARCN1 and inhibiting viral ribonucleoprotein activity. |
The Journal of general virology |
32 |
26498766 |
| 2019 |
Sphingolipids in COPD. |
European respiratory review : an official journal of the European Respiratory Society |
31 |
31694841 |
| 2013 |
Development of new drugs for COPD. |
Current medicinal chemistry |
31 |
22963554 |
| 2011 |
Toll-like receptor expression in smokers with and without COPD. |
Respiratory medicine |
31 |
21439805 |
| 2018 |
The DNA repair transcriptome in severe COPD. |
The European respiratory journal |
29 |
30190272 |
| 2015 |
Candidate genes for COPD: current evidence and research. |
International journal of chronic obstructive pulmonary disease |
29 |
26527870 |
| 2014 |
Sputum ADAM8 expression is increased in severe asthma and COPD. |
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology |
29 |
24147597 |
| 2007 |
A review of etiologies of depression in COPD. |
International journal of chronic obstructive pulmonary disease |
29 |
18268923 |
| 2013 |
Metabolic derangements in COPD muscle dysfunction. |
Journal of applied physiology (Bethesda, Md. : 1985) |
28 |
23288549 |
| 2020 |
RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD. |
Allergy |
27 |
32799375 |
| 2015 |
Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities. |
Chest |
27 |
26204554 |
| 2023 |
Extracellular vesicles and COPD: foe or friend? |
Journal of nanobiotechnology |
26 |
37147634 |
| 2022 |
Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review. |
Respiratory research |
25 |
35382831 |